Fate Therapeutics, Inc.FATENASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-34.7%
5Y CAGR-50.8%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-34.7%/yr
vs -18.1%/yr prior
5Y CAGR
-50.8%/yr
Recent acceleration
Acceleration
-16.5pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.56 | -4.3% |
| 2024 | 0.59 | -41.1% |
| 2023 | 1.00 | -50.5% |
| 2022 | 2.02 | -75.3% |
| 2021 | 8.17 | -58.1% |
| 2020 | 19.49 | +257.4% |
| 2019 | 5.45 | +21.4% |
| 2018 | 4.49 | +35.2% |
| 2017 | 3.32 | +205.0% |
| 2016 | 1.09 | - |